Backbone modifications in oligonucleotides and peptide nucleic acid systems

Current Opinion in Structural Biology

Volumn 5, Issue 3, 1995, Pages 343-355

  De Mesmaeker, Alain ^a   Altmann, Karl Heinz ^a   Waldner, Adrian ^a   Wendeborn, Sebastian ^a  

^a CIBA GEIGY LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTISENSE OLIGONUCLEOTIDE; DEOXYRIBONUCLEOTIDE; NUCLEIC ACID; OLIGONUCLEOTIDE; PEPTIDE; PHOSPHORUS;

CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; GENE REPRESSION; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW;

ANIMAL; HUMAN; MOLECULAR STRUCTURE; NUCLEIC ACIDS; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE;

EID: 0029093853     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-440X(95)80096-4     Document Type: Article

References (92)

1. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.
2. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus
3. Nonionic nucleic acid analogues. Synthesis and characterization of dideoxyribonucleoside methylphosphorates
4. Cationic oligonucleotides
5. Syntheses and properties of adenine and thymine nucleoside alkyl phosphotriesters, the neutral analogs of dinucleoside monophosphates
6. Phosphorodithioate DNA as potential therapeutic drug
7. Antisense oligonucleotides: a new therapeutic principle
8. Current concepts in antisense drug design
9. Synthesis of Oligonucleotide Analogues with Modified Backbones
10. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines
11. Evaluation of some properties of phosphorodithioate oligodeoxyribonucleotides for antisense application
12. Effect of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus Herpes Simplex virus infection
13. Antisense oligonucleotides: Stereocontrolled synthesis of phosphorothioate oligonucleotides
14. Stereocontrolled Synthesis of Oligo(nucleoside phosphorothioate)s
15. Pharmacokinetics of an antisense phosphorothioate oligodeoxynucleotide against rev from human immunodeficiency virus type 1 in the adult male rat following single injections and continuous infusion.
16. Characterization of the nuclear binding sites of oligodeoxyribonucleotides and their analogs
17. Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells
18. Cellular uptake of phosphorothioate oligodeoxynucleotides is negatively affected by the cell density in a transformed rat tracheal epithelial cell line: implication for antisense approaches
19. Differential distribution of oligodeoxynucleotides in developing organs with epithelial-mesenchymal interactions
20. Use of cationic lipids to enhance the biological activity of antisense oligonucleotides
21. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate and mixed phosphorothioate and methylphosphonate oligonucleotides
22. Synthesis of phosphorothioate-methylphosphonate oligonucleotide co-polymers
23. Phosphorodithioate DNA as a potential therapeutic drug
24. Synthesis of deoxycytidine oligomers containing phosphorodithioate linkages
25. Oligonucleoside methylphosphonates as antisense reagents
26. Synthesis of specific diastereomers of a DNA methylphosphonate heptamer, d(CpCpApApApCpA), and stability of base pairing with the normal DNA octamer d(TpGpTpTpTpGpGpC)
27. Use of EDTA derivatisation to characterize interactions between oligodeoxyribonucleotide methylphosphonates and nucleic acids
28. Effect of ionic strength on the hybridization of oligodeoxynucleotides with reduced charge due to methylphosphonate linkage to unmodified oligodeoxynucleotides containing the complementary sequence
29. Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonate
30. Antisense oligonucleotide methylphosphonates and their derivatives
31. Biochemical and biological effects of nonionic nucleic acid methylphosphonates
32. Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkage
33. Modulation of drug resistance in a Daunorubicin resistance subline with oligonucleoside methylphosphonates
34. Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3' end of 16S rRNA
35. Phosphoramidate analogues of DNA: synthesis and thermal stability of heteroduplexes
36. Cationic oligonucleotides
37. Hybridization of alternating cationic/anionic oligonucleotides to RNA segments
38. 2
39. Boron-containing nucleic acids. 2. Synthesis of oligodeoxynucleotide boranophosphonates
40. Hydroxymethylphosphonate: novel oligonucleotide analogue
41. Synthesis and selective cleavage of an oligodeoxynucleotide containing a bridged internucleotide 5'-phosphorothioate linkage
42. Sequence-and strand-specific cleavage in oligodeoxyribonucleotides and DNA containing 3'-thiothymidine
43. Synthesis and properties of dithymidine phosphate analogues containing 3'-thiothymidine
44. Synthesis and properties of oligonucleotides containing aminodeoxythymidine units
45. Synthesis and selective cleavage of an oligodeoxynucleotide containing bridged non-chiral internucleotide 3'-phosphoramidate linkage
46. Oligodeoxyribonucleotide N3′→P5′ phosphoramidates: synthesis and hybridization properties
47. Effect of a single 3′-methylene phosphonate linkage on the conformation of an A-DNA octamer double helix
48. Synthesis of 5′-deoxy-5′-methylphosphonate linked thymidine oligonucleotides.
49. Ureas as Backbone Replacements for the Phosphodiester Linkage in Oligonucleotides
50. Synthesis of oligodeoxyribonucleotides containing dimers with carbamate moieties as replacement of the natural phosphodiester linkage
51. Uncharged stereoregular nucleic acid analogues. 1. Synthesis of a cytosine containing oligomer with carbamate internucleoside linkages
52. Synthesis of di-, tri- and tetrameric building blocks with novel carbamate internucleoside linkages and their incorporation into oligonucleotides
53. Synthesis, enzymatic stability and base-pairing properties of oligothymidylates containing thymidine dimers with different N-substituted guanidine linkages
54. Synthesis of an oxyamide linked nucleotide dimer and incorporation into antisense oligonucleotide sequences
55. Thiocarbamates as Novel Backbone Analogs in Oligonucleotides
56. Oligonucleotides with a nuclease-resistant sulfur-based linkage
57. Synthesis of thymidine dimer derivatives containing an amide linkage and their incorporation into oligodeoxyribonucleotides
58. Replacement of the phosphodiester linkage in oligonucleotides: comparison of two structural amide isomers
59. Amides as Substitute for the Phosphodiester Linkage in Antisense Oligonucleotides
60. Amides as a new type of backbone modification in oligonucleotides
61. Synthesis and hybridization properties of amide-linked thymidine dimers incorporated into oligodeoxynucleotides
62. Antisense Oligonucleotides with Alternating Phosphodiester-"Amide-3" Linkages
63. Comparison of two amides as backbone replacement of the phosphodiester linkage in oligodeoxyribonucleotides
64. Oligodeoxynucleotides containing 3′-allylether, 3′-allylsulfide and their saturated derivatives as phosphate mimics
65. An approach to the structure determination of nucleic acid analogues hybridized to RNA. NMR studies of a duplex between 2′-OMe RNA and an oligonucleotide containing a single amide backbone modification
66. Synthesis of a carboxamide linked T*T dimer and its incorporation in oligonucleotides
67. Oligonucleosides: synthesis of a novel methylhydroxylamine-linked nucleoside dimer and its incorporation into antisense sequences
68. Synthesis and incorporation of methyleneoxy(methylimino)-linked thymidine dimer into antisense oligonucleosides
69. Deoxyoligonucleotide analogs based on formacetal linkages
70. Synthesis and binding properties of pyrimidine oligodeoxynucleoside analogs containing neutral phosphodiester replacements: the formacetal and 3′-thioformacetal internucleoside linkages
71. Unusual conformation of a 3′-thioformacetal linkage in a DNA duplex
72. Peptide nucleic acids (PNA). Oligonucleotide analogs with an achiral peptide backbone
73. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide
74. Recognition of guanine and adenine in DNA by cytosine and thymine containing peptide nucleic acids (PNA)
75. Right-handed triplex formed between peptide nucleic acid PNA-T8 and poly(dA) shown by linear and circular dichroism spectroscopy
76. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen bonding rules
77. Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets
78. Structure-Activity Studies of the Binding of Modified Peptide Nucleic Acids (PNAs) to DNA
79. Peptide nucleic acids (PNA) with a chiral backbone based on alanine
80. DNA-like double helix formed by peptide nucleic acid
81. Sequence specific inhibition of DNA restriction enzyme cleavage by PNA
82. Antisense and antigene potential of peptide nucleic acids
83. Strand-invasion of duplex DNA by peptide nucleic acid oligomers
84. DNA unwinding upon strand-displacement binding of a thymine-substituted polyamide to double stranded DNa
85. NMR solution structure of a peptide nucleic acid complexed with RNA
86. Structural characterization of PNA-DNA duplexes by NMR. Evidence for DNA in a B-like conformation
87. Single base pair mutation analysis by PNA directed PCR clamping
88. Sequence selective double strand DNA cleavage by peptide nucleic acid (PNA) targeting using nuclease S1
89. Peptide nucleic acid.DNA strand displacement loops as artificial transcription promoters.
90. Comparison of rigid and flexible backbones in antisense oligonucleotides
91. Solid-phase synthesis and hybridization properties of DNA containing sulfide-linked dinucleosides
92. 2 linkages